Establishment Labs Holdings Inc. (ESTA) vs Vir Biotechnology, Inc. (VIR)

A side-by-side comparison of Establishment Labs Holdings Inc. and Vir Biotechnology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ESTA vs VIR

growth of $100 · dividends reinvested · last 7y
ESTA +283.8% (+21.2%/yr)VIR -16.0% (-2.5%/yr)ESTA compounded faster over this window
0100200300400500Start $100202120232025$384$84
ESTA VIR

ESTA vs VIR: by the numbers

  • •VIR is the larger company ($1.96B vs $1.92B market cap).
  • •Both run net losses; ESTA's is the smaller (-15.82% vs -83.00% net margin).
  • •ESTA grew revenue faster over the past five years (17.02% vs 11.22% CAGR).

Metrics side by side

Valuation

MetricESTAVIR
P/S ratio7.826.45
P/B ratio88.931.99

Profitability

MetricESTAVIR
Gross margin70.49%82.92%
Operating margin-18.48%-682.68%
Net margin-15.82%-83.00%
ROE-179.99%-25.62%
ROIC-6.53%-24.09%

Growth (annualized)

MetricESTAVIR
Revenue CAGR (5Y)17.02%11.22%
Total return CAGR (5Y)-1.56%-19.71%

Frequently asked

Which has grown faster, ESTA or VIR?
Over the past five years, ESTA grew revenue faster — ESTA at a 17.02% CAGR versus VIR at 11.22%.
How have ESTA and VIR total returns compared?
Over the past 5 years, ESTA delivered -1.56% and VIR delivered -19.71% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.